Startup Atlas
proximabio.com
Proxima describes itself as pursuing AI drug discovery with a data generation platform.
Last successful source check: 2026-10-26
Company website: proximabio.com
Inclusion criteria were assessed against available sources. Private-company status and category may be model assessments; no hands-on test or independent confirmation is implied.
- Status
- Unknown or unverified
- Category
- Unknown or unverified
- Validated funding
- Unknown or unverified
- Pricing excerpt
- Unknown or unverified
- Open roles
- Unknown or unverified
- AI visibility
- Unmeasured. Visibility products are held.
What it does
Proxima and Halda Therapeutics announced an alliance to discover RIPTAC medicines. Source
What the company says (captured excerpt)
closes an $80 million seed round backed by DCVC, Nvidia, and others to advance AI drug discovery with an advanced data generation platform. August 19, 2025 Proxima and Halda Therapeutics Forge Alliance to Discover Next-Generation RIPTAC Medicines Proxima and Ha
Captured company wording; it may be incomplete. No hands-on test is implied.
Identity & inclusion
Name: Unknown or unverified; last successful source check 2026-10-26
Legal name: Unknown or unverified; last successful source check 2026-10-26
Privately held: Yes · Model assessment
Founded: Unknown or unverified; last successful source check 2026-10-26
Pricing
Unknown or unverified; last successful source check 2026-10-26
Validated price change history is unavailable in this snapshot.
How it differs
Model comparison is unmeasured; no checked comparison with five nearest rivals is available in this snapshot.
Launches and changes
Validated product launch and change history is unavailable in this snapshot.
Team signals
Open roles: Unknown in this snapshot.
Departments are unavailable in this snapshot.
Similar startups
Validated similar startups are unavailable in this snapshot.
Funding & backers
Unknown or unverified; last successful source check 2026-10-26
Unknown or unverified; last successful source check 2026-10-26
Sources & check dates
Checked 2026-10-26
SHA-256 050fa735565c96ef2583691765d516e79c7d15acc5e0b91ef6040b0c47d504a0closes an $80 million seed round backed by DCVC, Nvidia, and others to advance AI drug discovery with an advanced data generation platform. August 19, 2025 Proxima and Halda Therapeutics Forge Alliance to Discover Next-Generation RIPTAC Medicines Proxima and Ha